Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Anadenanthera colubrina
An Andean psychoactive seed used by shamans in Argentina and Bolivia for healing rituals.
Vilca (Anadenanthera colubrina) is a psychoactive seed traditionally used by Andean shamans for healing and divination rituals. Its primary active compounds include bufotenine, DMT, and 5-MeO-DMT, which produce intense psychedelic effects via serotonin receptor agonism. Evidence is limited to traditional use and preliminary pharmacological studies.
The tryptamine alkaloids in Vilca seeds, particularly bufotenine and DMT, act as agonists at serotonin 5-HT2A, 5-HT2C, and 5-HT1A receptors, leading to altered perception and mystical experiences. Bufotenine also exhibits affinity for sigma-1 receptors and may inhibit monoamine oxidase (MAO) at high concentrations, though its oral bioavailability is low without MAO inhibition. These mechanisms collectively produce the entheogenic and visionary effects reported in shamanic contexts.
An Andean psychoactive seed used by shamans in Argentina and Bolivia for healing rituals.
Vilca (Anadenanthera colubrina) is a psychoactive seed traditionally used by Andean shamans for healing and divination rituals. Its primary active compounds include bufotenine, DMT, and 5-MeO-DMT, which produce intense psychedelic effects via serotonin receptor agonism. Evidence is limited to traditional use and preliminary pharmacological studies.
The tryptamine alkaloids in Vilca seeds, particularly bufotenine and DMT, act as agonists at serotonin 5-HT2A, 5-HT2C, and 5-HT1A receptors, leading to altered perception and mystical experiences. Bufotenine also exhibits affinity for sigma-1 receptors and may inhibit monoamine oxidase (MAO) at high concentrations, though its oral bioavailability is low without MAO inhibition. These mechanisms collectively produce the entheogenic and visionary effects reported in shamanic contexts.